Alembic Pharma gets USFDA nod for conjunctivitis treatment drug

Alembic Pharma gets USFDA nod for conjunctivitis treatment drug The approved product is therapeutically equivalent to the reference listed drug Optivar Ophthalmic Solution of Mylan Specialty L P.

No comments:

Post a Comment